ROBERTS LAB INC has a total of 21 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are ACUCELA INC, NAVITOR PHARMACEUTICALS INC and PELOTON THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Argentina | 2 | |
#5 | Australia | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Brazil | 1 | |
#8 | Ireland | 1 | |
#9 | Japan | 1 | |
#10 | Mexico | 1 | |
#11 | Uruguay | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Lang Philip C | 14 |
#2 | Lang Philip Charles | 3 |
#3 | Fears Robin Bradshaw | 1 |
#4 | Duff David Alexander | 1 |
Publication | Filing date | Title |
---|---|---|
US6194420B1 | 2-amino-5,6-dichloro-3,4-dihydroquinazoline, its method of making and using and pharmaceutical compositions thereof | |
US5962488A | Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives | |
CA2171073A1 | Process for the preparation of ethyl-n-(2,3 dichloro-6- nitrobenzyl) glycine |